-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$113.33142.52% Upside
Korro Bio, Inc. Frequently Asked Questions
-
What analysts cover Korro Bio, Inc.?
Korro Bio, Inc. has been rated by research analysts at RBC Capital, BMO Capital, H.C. Wainwright in the past 90 days.